| # | Drug | Count |
|---|---|---|
| 0 | NIFEDIPINE | 12 |
| 1 | PREDNISONE | 11 |
| 2 | TACROLIMUS | 11 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 11 |
| 4 | TACROLIMUS OINTMENT 0.1% | 11 |
| 5 | MYCOPHENOLATE MOFETIL | 10 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 10 |
| 7 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 8 |
| 8 | DUPILUMAB | 4 |
| 9 | IBUPFROFEN | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 8 | 0.0010 |
| 1 | VAMOROLONE | 1 | 0.0006 |
| 2 | NIFEDIPINE | 12 | 0.0003 |
| 3 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 2 | 0.0002 |
| 4 | FENFLURAMINE | 1 | 0.0002 |
| 5 | ELOSULFASE ALFA | 1 | 0.0002 |
| 6 | SPARSENTAN | 1 | 0.0001 |
| 7 | TEZEPELUMAB-EKKO | 1 | 0.0001 |
| 8 | OFLOXACIN OTIC SOLUTION | 1 | 0.0001 |
| 9 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Thymic Stromal Lymphopoietin Blocker [EPC] | 1 | 0.0001 |
| 2 | Interleukin-17A Antagonist [EPC] | 4 | 0.0001 |
| 3 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 4 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 6 | Potassium Binder [EPC] | 1 | 0.0001 |
| 7 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 8 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |